申请人:British Biotech Pharmaceuticals
公开号:US06479502B1
公开(公告)日:2002-11-12
Compounds of formula (I) are matrix metalloprotemase inhibitors wherein X represents a carboxylic acid group —COOH, or a hydroxamic acid group —CONHOH;R2 represents a radical of formula (II): R3—(ALK)m—(Q)p—(ALK)n., and W represents a cyclic amino radical of formula (IIIA) or (IIIB):
公式(I)的化合物是基质金属蛋白酶抑制剂,其中X代表羧酸基—COOH或羟胺酸基—CONHOH;R2代表公式(II)的基团:R3—(ALK)m—(Q)p—(ALK)n.,W代表公式(IIIA)或(IIIB)的环状氨基基团: